Breaking News

Moderna Finalizes Agreement to Establish Kenya mRNA Manufacturing Facility

To build a state-of-the-art mRNA facility capable of producing up to 500 million doses of vaccines each year.

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya, finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya. This will be Moderna’s first mRNA manufacturing facility in Africa. In partnership with the Government of the Republic of Kenya, Moderna will build a state-of-the-art mRNA facility in Kenya to produce up to 500 million doses of vaccines each year. The company expe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters